section name header

Basics ⬇

Basics

Overview

  • Emerging infectious agents that are highly adapted to preferential reservoir hosts, where they establish chronic intraerythrocytic bacteremia.
  • Agents-small, curved, facultative fastidious intracellular argyrophilic, hemotrophic Gram-negative rod (bacilli) bacteria.
  • Vector transmitted (fleas, ticks).
  • Human syndrome-wide variety of clinical syndromes, including, most commonly, cat scratch disease, typified by regional lymphadenopathy after a cat scratch or bite distal to the involved lymph node; worldwide occurrence; estimated >25,000 cases/year in United States; >2,000 cases require hospitalization; almost no fatalities.
  • Cats-usually asymptomatic.
  • Dogs-emerging clinical syndrome.
  • Seasonal; more cases reported between July and January.

Signalment

  • Dogs and cats.
  • Majority of human patients (80%) <21 years of age; more males than females (1.2:1).

Signs

Human

  • Erythematous papule at inoculation site (scratch, bite); then unilateral regional lymphadenopathy (painful, often suppurative) in 3–10 days (>90% of cases).
  • Mild fever.
  • Chills-infrequent.
  • Malaise.
  • Anorexia.
  • Myalgia.
  • Nausea.
  • Atypical manifestations (in up to 25% of cases)-encephalopathy (1–7%); palpebral conjunctivitis (3–5%); meningitis; optic neuritis; osteolytic lesions; granulomatous hepatitis; granulomatous splenitis; pneumonia; endocarditis.

Cats

  • No signs of illness.
  • Between 5 and 60% seropositive, depending on geographical area.
  • Lymphoid hyperplasia (sometimes), uveitis, endocarditis (rare), self-limiting fever.

Dogs

Expanding spectrum of disease including endocarditis, myocarditis, granulomatous lymphadenitis, rhinitis, vasculitis, uveitis, chorioretinitis, arthritis, meningoencephalitis, anemia, thrombocytopenia.

Causes & Risk Factors

  • Contact with domestic kittens and cats (>90%), particularly young cats with fleas.
  • Scratched by cat-up to 83%.
  • Up to 95% of cats residing in households of affected humans are seropositive.
  • Localized infections in immunocompetent; systemic infection in immunocompromised.
  • Dogs: risk factors include tick and flea exposure and rural environment.
  • Feline bartonella include: Bartonella henselae, B. clarridgeiae, B. koehlerae, B. bovis, B. quintana.
  • Canine bartonella include: B. vinsonii ssp. berkhoffii, B. henselae, B. clarridgeiae, B. washoensis, B. quintana, B. rochalimae, B. elizabethae.

Diagnosis ⬆ ⬇

Diagnosis

Differential Diagnosis

  • Benign adenopathy in human children and young adults-most common cause.
  • History of contact with a cat.
  • Formation of a papule at the site of primary inoculation (scratch or bite).
  • Compatible clinical picture-unilateral regional lymphadenitis.
  • Exclusion of other identifiable causes.
  • Characteristic histopathologic findings.
  • Serologic tests-indirect fluorescent antibody for B. henselae.
  • Positive skin test no longer used.
  • Other causes of lymphadenopathy-lymphogranuloma venereum; syphilis; typical or atypical tuberculosis; other forms of bacterial adenitis; sporotrichosis; tularemia; brucellosis; histoplasmosis; sarcoidosis; toxoplasmosis; infectious mononucleosis; and benign or malignant tumors.
  • Dogs: co-infections with other tick-borne diseases (Ehrlichia, Babesia).

CBC/Biochemistry/Urinalysis

Non-contributory

Other Laboratory Tests

  • Indirect fluorescent antibody test.
  • Enzyme immunoassay-IgG antibodies to B. henselae (Quest Diagnostics Nichols Institute Laboratory, Valencia, CA).
  • Culture-on enriched (blood-containing) media in presence of 5% carbon dioxide at 35–37°C; fastidious and slow growing; requires 14–30 days.
  • PCR amplification of bacterial DNA from lesions (Galaxy Diagnostics, Research Triangle Park, NC).

Pathologic Findings

  • Histopathology of lymph nodes-non-specific inflammatory reaction, including granuloma, microabscess, and necrosis.
  • Warthin-Starry silver stain-bacilli.

Treatment ⬆ ⬇

Treatment

Medications ⬆ ⬇

Medications

Drug(s)

  • Specific antimicrobials-not efficacious.
  • Most cases spontaneously resolve in a few weeks or months.
  • Severe cases-antibiotic therapy (gentamicin, doxycycline, erythromycin, azithromycin) based on the antimicrobial susceptibility of B. henselae may be appropriate.
  • Dogs-optimal therapy not established but likely long-term (4–6 weeks) antibiotics consisting of macrolides (erythromycin, azithromycin).

Follow-Up ⬆ ⬇

Follow-Up

Prevention/Avoidance

Immunocompromised people should avoid young cats.

Possible Complications

Uncommon

Miscellaneous ⬆

Miscellaneous

Zoonotic Potential

The risk of transfer of organisms from infected dogs and cats to people is unknown, although infected cats probably serve as a source of organisms for fleas that are thought to transmit the infection to humans by way of contaminating wounds with infected flea feces (i.e., cat scratch disease).

  • Dogs may also serve as chronically infected blood reservoirs for Bartonella species, which may be spread by arthropod vectors to people.

Abbreviations

  • PCR = polymerase chain reaction

Author J. Paul Woods

Consulting Editor Stephen C. Barr

Suggested Reading

Guptill-Yoran L, Breitschwerdt EB, Chomel BB. Bartonellosis. In: Greene CE, ed., Infectious Diseases of the Dog and Cat, 4th ed. Philadelphia: Saunders Elsevier, 2012, pp. 543–563.

Pennisi MG, Marsilio F, Hartmann K, et al. Bartonella species infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg 2013, 15:563–569.

Zangwell KM. Cat scratch disease and other Bartonella infections. Adv Exp Med Biol 2013, 764:159–166.